Bayer plans $10.5 billion settlement for Roundup cancer lawsuits
The German chemical giant aims to resolve current and future legal claims regarding its weedkiller. This massive plan includes a major class-action settlement.
Insights:
Bayer AG , headquartered in Germany 
DE, is planning to announce a $10.5 billion settlement plan to resolve current and potential future cancer lawsuits in the United States 
US tied to its Roundup (herbicide). The proposal, which is currently under discussion, would include a $7.5 billion class-action settlement designed to cover suits filed in Missouri state court over a 20-year period and $3 billion to settle existing U.S. cases. If implemented, the move would alter the litigation exposure and financial liabilities of the company related to Roundup claims.
DE, is planning to announce a $10.5 billion settlement plan to resolve current and potential future cancer lawsuits in the United States US tied to its Roundup (herbicide). The proposal, which is currently under discussion, would include a $7.5 billion class-action settlement designed to cover suits filed in Missouri state court over a 20-year period and $3 billion to settle existing U.S. cases. If implemented, the move would alter the litigation exposure and financial liabilities of the company related to Roundup claims.
